Search This Blog

Thursday, June 1, 2023

Nonprofit Allina Health System Cuts Off Patients With Medical Debt

 Many hospitals in the United States use aggressive tactics to collect medical debt. They flood local courts with collections lawsuits. They garnish patients’ wages. They seize their tax refunds.

But a wealthy nonprofit health system in the Midwest is among those taking things a step further: withholding care from patients who have unpaid medical bills.

Allina Health System, which runs more than 100 hospitals and clinics in Minnesota and Wisconsin and brings in $4 billion a year in revenue, sometimes rejects patients who are deep in debt, according to internal documents and interviews with doctors, nurses and patients.

Although Allina’s hospitals will treat anyone in emergency rooms, other services can be cut off for indebted patients, including children and those with chronic illnesses like diabetes and depression. Patients aren’t allowed back until they pay off their debt entirely.

Nonprofit hospitals like Allina get enormous tax breaks in exchange for providing care for the poorest people in their communities. But a New York Times investigation last year found that over the past several decades, nonprofits have fallen short of their charitable missions, with few consequences.

Allina has an explicit policy for cutting off patients who owe money for services they received at the health system’s 90 clinics. A 12-page document reviewed by The Times instructs Allina’s staff on how to cancel appointments for patients with at least $4,500 of unpaid debt. The policy walks through how to lock their electronic health records so that staffers cannot schedule future appointments.

“These are the poorest patients who have the most severe medical problems,” said Matt Hoffman, an Allina primary care doctor in Vadnais Heights, Minn. “These are the patients that need our care the most.”

Allina Health said it has a robust financial assistance program that in an average year helps over 12,000 of its 1.9 million patients with medical bills. The hospital system cuts off patients only if they have racked up at least $1,500 of unpaid debt three separate times. It contacts them by phone and with repeated letters that include information about applying for financial help, said Conny Bergerson, a hospital spokeswoman.

“Allina Health’s goal is, and will always be, to have zero patients go without services for financial reasons,” Ms. Bergerson said. She said that cutting off services was “rare” but declined to provide information on how often it happens.

Allina suspended its policy of cutting off patients in March 2020, at the onset of the coronavirus pandemic, before reinstating it in April 2021.

ImageDr. Rita Raverty, leaning against a fence post, in a field.
“Nobody wins when patients can’t get preventive care,” said Dr. Rita Raverty, a primary care doctor who works at an Allina clinic.Credit...Tim Gruber for The New York Times
Dr. Rita Raverty, leaning against a fence post, in a field.

An estimated 100 million Americans have medical debts. Their bills make up about half of all outstanding debt in the country.

About 20 percent of hospitals nationwide have debt-collection policies that allow them to cancel care, according to an investigation last year by KFF Health News. Many of those are nonprofits. The government does not track how often hospitals withhold care.

Under federal law, hospitals are required to treat everyone who comes to the emergency room, regardless of their ability to pay. But the law — called the Emergency Medical Treatment and Labor Act — is silent on how health systems should treat patients who need other kinds of lifesaving care, like those with aggressive cancers or diabetes.

In 2020, thanks to its nonprofit status, Allina avoided roughly $266 million in state, local and federal taxes, according to the Lown Institute, a think tank that studies health care.

In exchange, the Internal Revenue Service requires Allina and thousands of other nonprofit hospital systems to benefit their local communities, including by providing free or reduced-cost care to patients with low incomes.

But the federal rules do not dictate how poor a patient needs to be to qualify for free care. In 2020, Allina spent less than half of 1 percent of its expenses on charity care, well below the nationwide average of about 2 percent for nonprofit hospitals, according to an analysis of hospital financial filings by Ge Bai, a professor at the Johns Hopkins Bloomberg School of Public Health.

Allina is one of Minnesota’s largest health systems, having largely grown through acquisitions. Since 2013, its annual profits have ranged from $30 million to $380 million. Last year was the first in the past decade when it lost money, largely owing to investment losses.

The financial success has paid dividends. Allina’s president earned $3.5 million in 2021, the most recent year for which data is available. The health system recently built a $12 million conference center.

Yet Allina sometimes plays hardball with patients. Doctors have become accustomed to seeing messages in the electronic medical record notifying them that a patient “will no longer be eligible to receive care” because of “unpaid medical balances.”

Dr. Rita Raverty, a primary care doctor who works at an Allina clinic, said the notifications were alarming because they meant she could not provide continuous care for some of her patients facing a number of health risks.

“Nobody wins when patients can’t get preventive care,” Dr. Raverty said. “It creates worse disease outcomes when you’re not catching things early.”

Doctors and patients described being unable to complete medical forms that children needed to enroll in day care or show proof of vaccination for school.

Serena Gragert, who worked as a scheduler at an Allina clinic in Minneapolis until 2021, said the computer system simply wouldn’t let her book future appointments for some patients with outstanding balances.

Image
Serena Gragert, wearing a blue blouse and black trousers, stands in front of a grouping of trees.
Serena Gragert worked as an appointment scheduler at an Allina clinic in Minneapolis. The scheduling system blocked her from booking patients who had been flagged for unpaid balances.Credit...Tim Gruber for The New York Times
Serena Gragert, wearing a blue blouse and black trousers, stands in front of a grouping of trees.

Ms. Gragert and other Allina employees said some of the patients who were kicked out had incomes low enough to qualify for Medicaid, the federal-state insurance program for poor people. That also means those patients would be eligible for free care under Allina’s own financial assistance policy — something many patients are unaware exists when they seek treatment.

Ms. Bergerson, the Allina spokeswoman, did not dispute that but said the health system goes “to tremendous lengths to assist patients with their financial obligations for medical care.”

Allina employees said the policy has forced them to ration care.

Beth Gunhus, a pediatric nurse practitioner, recalled a case in which a mother brought in her three children. One had scabies, an intensely itchy skin condition caused by mites burrowing into the body. She wanted to follow best practices and treat the entire family, who were sharing one bed in a single room they rented, to ensure it didn’t spread further. But she could write a prescription for only two of the children. The third’s account was locked because of unpaid bills.

“There are so many better ways of saving money than what we’re doing,” Ms. Gunhus said.

Allina says the policy applies only to debts related to care provided by its clinics, not its hospitals. But patients said in interviews that they got cut off after falling into debt for services they received at Allina’s hospitals.

Because Allina is the dominant health system in some rural parts of Minnesota, getting kicked out can leave patients with few options.

Jennifer Blaido lives in Isanti, a small town outside Minneapolis, and Allina owns the only hospital there. Ms. Blaido, a mechanic, said she racked up nearly $200,000 in bills from a two-week stay at Allina’s Mercy Hospital in 2009 for complications from pneumonia, along with several visits to the emergency department for asthma flare-ups. Ms. Blaido, a mother of four, said most of the hospital stay was not covered by her health insurance and she was unable to scrounge together enough money to make a dent in the debt.

Last year, Ms. Blaido had a cancer scare and said she couldn’t get an appointment with a doctor at Mercy Hospital. She had to drive more than an hour to get examined at a health system unconnected to Allina.

Allina does not make this policy explicit to patients. It is not mentioned in the health system’s list of “frequently asked questions” about billing practices. In at least one case, Allina has denied that it even existed.

In a lawsuit filed last year in state court in Minnesota, Allina sued a couple, Jordan and JoLynda Anderson, for nearly $10,000 in unpaid medical bills.

In court filings, the couple described how Allina canceled Ms. Anderson’s appointments and told her that she could not book new ones until she had set up three separate payment plans — one with the health system and two with its debt collectors.

Even after setting up those payment plans, which totaled $580 a month, the canceled appointments were never restored. Allina allows patients to come back only after they have paid the entire debt.

Ms. Anderson recalls being devastated about losing her visit to an endocrinologist that specialized in a chronic condition she has. She had already been waiting four months for the appointment, and was unable to get a new one.

“It felt like I was being punished, and the punishment was you get to stay ill,” she said.

Ms. Bergerson declined to comment on these cases, citing patient privacy.

When the Andersons asked in court for a copy of Allina’s policy of barring patients with unpaid bills, the hospital’s lawyers responded: “Allina does not have a written policy regarding the canceling of services or termination of scheduled and/or physician referral services or appointments for unpaid debts.”

In fact, Allina’s policy, which was created in 2006, instructs employees on how to do exactly that. Among other things, it tells staff to “cancel any future appointments the patient has scheduled at any clinic.”

It does provide a few ways for patients to continue being seen despite their unpaid bills. One is by getting approved for a loan through the hospital. Another is by filing for bankruptcy.

https://www.nytimes.com/2023/06/01/business/allina-health-hospital-debt.html

Novan Focuses Strategic Direction and Announces Restructuring

  Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum –

– Process to explore a sale or out-license of commercial assets or other business transaction continues –

– Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3% –

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that following an evaluation of its commercial and developmental stage assets, it has decided to sharpen its focus and resources on berdazimer gel, 10.3% (SB206) and announced that it continues to explore strategic alternatives, with a focus on its commercial product portfolio and a sale or out-license of one or more of its commercial products.

Novan conducted a deliberate and thorough review of its commercial and development portfolio of assets to determine a path to optimally deploy capital and maximize shareholder value. Following this review, the Company, has initiated a process to explore a sale or out-license of its commercial assets, including RHOFADE, MINOLIRA, and CLODERM. The Company will immediately reduce certain of its operating expenses currently supporting its commercial operations.

“We continue to face serious challenges achieving profitability with our commercial assets in the current economic environment, while also endeavoring to extend our cash runway through the PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3%,” said Paula Brown Stafford, President and CEO. “We have been evaluating our portfolio of assets for some time to determine the optimal path for a product, if approved, to treat molluscum contagiosum, an unmet medical need. After careful consideration, we have made the strategic decision to implement a reduction in force of our commercial team and continue to explore a sale or out-license of our commercial assets. We will use our resources, plus the proceeds from any dilutive or non-dilutive financing or any strategic transaction, to work in earnest to capture the potential value of berdazimer gel, 10.3% by supporting the ongoing NDA review process.”

Elon Musk Encouraged By Government To Expand Business, Investment In Shanghai

 Tesla's relationship with China continues to look cozy heading into the second half of 2023, with Shanghai party chief Chen Jining reportedly encouraging Elon Musk to expand his business in China.

At the conclusion of a trip through China for Musk, on Thursday Bloomberg reported in a wrap-up that Musk was told to expand his investment and businesses in Shanghai, citing an official government statement. 

The city is reportedly seeking "deepening cooperation with Tesla on electric vehicles and energy storage sector". Tesla "hopes to keep deepening cooperation" with the city, Bloomberg noted. 

Recall, we wrote days ago how Musk was visiting China for the first time in three years. We reported yesterday that Musk told Chinese Foreign Minister Qin Gang in Beijing that Tesla opposes "decoupling" and is willing to invest more in China.

Dan Ives, an analyst at Wedbush, shared his thoughts on Musk's first visit to China in three years yesterday. He said the visit comes amid a worsening EV price war and stressed the importance for Tesla to capture a greater market share in China versus domestic competitors. 

 "Playing nice in the sandbox in Beijing is something the Street is laser-focused on to make sure there are no disruptions to Tesla's expansion," Ives wrote in the note. 

Elon Musk's tour of the country started earlier this week, on Tuesday. As we noted then, Tesla's second-biggest market, after the US, is China, where the company operates a massive factory in Shanghai. The world's second richest person met top Chinese officials and visited Tesla's Shanghai factory. 

CCP's mouthpiece Global Times tweeted earlier this month, "Shanghai will further deepen cooperation with Tesla, pushing its layout on autonomous driving, robots and other business sectors in the city." 

Despite souring relations between China and the US, Musk appears to be betting big on Shanghai production while other companies are rejiggering supply chains out of the world's second-largest economy to other friendlier countries. 

https://www.zerohedge.com/markets/elon-musk-encouraged-government-expand-business-investment-shanghai

Medicare to cover new Alzheimer's drug after full approval

 The Centers for Medicare & Medicaid Services said on Thursday that the U.S. Medicare health plan would cover new Alzheimer's drugs such as Eisai Co Ltd and Biogen Inc's Leqembi if they gain full U.S. approval.

Currently, Medicare - the government health plan for Americans 65 and over - will only pay for Alzheimer's disease drugs approved under the FDA's rigorous accelerated review if patients are enrolled in a clinical trial. 

https://finance.yahoo.com/news/medicare-cover-alzheimers-drug-full-130704773.html

Apple Savings Account Customers: Hard to Get Their Money Out of Goldman Sachs

Some customers said it has taken weeks to withdraw their money, and that the bank’s instructions have differed

 

Apple’s AAPL 1.32%increase; green up pointing triangle savings account, a partnership with Goldman Sachs GS -2.13%decrease; red down pointing triangle, launched in April to great fanfare. Some customers say it has been hard to get their money out. 

https://www.wsj.com/articles/apple-savings-account-customers-say-its-hard-to-get-their-money-out-of-goldman-sachs-bd8b9ccb

US debt-ceiling deal dooms Biden's revolutionary tax plans

 U.S. President Joe Biden's 2020 campaign promise to make wealthy Americans and corporations pay more in taxes to finance a range of social priorities breathed its last gasp, at least for this presidential term, with the debt ceiling deal he struck with Republicans on Saturday.

The deal to cap discretionary spending and suspend the debt ceiling contains no tax rate changes to raise revenue; it also slashes new funding Biden had allocated to the hollowed-out Internal Revenue Service. The agreement caps Republicans' successful defense of the debt-boosting 2017 Trump tax cuts against withering criticism from Biden and several attempts by his Democrats to reverse them for wealthy Americans.

Barring an unlikely Democratic sweep of the White House and both chambers of Congress in 2024, major changes to the U.S. tax code are now seen as largely off the table until the end of 2025, when the 2017 individual tax cuts expire. Then, tax experts predict lawmakers will be forced to agree on a major tax revamp.

"Things are getting set up for a big fiscal cliff in 2025. That's the next opportunity for major changes," said William McBride, vice president of federal tax policy for the Tax Foundation, a conservative think tank in Washington.

Polls show the idea of fighting glaring income inequality with tax increases on the wealthy and corporations is hugely popular with Democratic and Republican voters.

TAX CHANGES ARE TOUGH

Biden's unrealized campaign tax pledges illustrate the political difficulty of changing the U.S. tax code, barring a commanding majority in Congress.

His $4 trillion, two-part "Build Back Better" plan included infrastructure, clean energy incentives, workforce development, child care, paid family leave, free community college, expanded child tax credits and other initiatives.

He proposed over $3.5 trillion in new taxes, including raising the corporate rate to 28% from 21% and returning the top individual rate to 39.6% from 37% and taxing capital gains at those rates for Americans earning over $1 million. He promised no increases for those earning under $400,000 a year.

But opposition from Republicans and Democratic senators Joe Manchin and Kyrsten Sinema, now an Independent, forced Biden to scale back his revenue plans. He did manage to win new cryptocurrency tax reporting rules in the infrastructure bill and a new 15% corporate alternative minimum tax in the climate-focused Inflation Reduction Act, to achieve $238 billion in deficit cuts over 10 years.

Biden presented his tax hikes and social agenda one last time, largely for campaign purposes, in his fiscal 2024 budget request in March, proposing to raise $5.5 trillion in new revenue and cutting deficits by $3 trillion over a decade.

But in the debt-ceiling negotiations, the president did not insist on tax revenue-raisers, and sacrificed part of his revenue crown jewel - $80 billion in new funding over a decade to modernize the IRS to beef up enforcement against tax cheats. The IRS will cede $20 billion over two years to other spending priorities.

"House Republicans have successfully blocked every penny of President Biden’s tax hikes on families, farmers, and small businesses in the debt ceiling deal and protected the 2017 Tax Cuts and Jobs Act from repeal," said U.S. House Ways and Means Chairman Jason Smith.

The Missouri Republican added that Americans want Congress to build on the Trump tax cuts "with more tax relief."

2024 CAMPAIGN ISSUE

The 2024 presidential election is already becoming a new battle ground over taxes as both parties posture over the expiration of 2017 individual tax cuts and the overall level of taxation in the economy.

U.S. taxes are low compared with other wealthy countries, ranking 32nd out of 38 Organisation for Economic Co-operation and Development countries as a percentage of GDP, with a 2021 ratio of 26.8% - well below the group's 34.1% average.

White House spokesperson Michael Kikukawa said Biden would continue pushing Congress to make the "super-wealthy and biggest corporations" pay their fair share in taxes.

"This agenda is overwhelmingly popular with bipartisan majorities of the American people, and would reduce the deficit by trillions of dollars without raising taxes a penny on those making less than $400,000," Kikukawa said.

Republicans will argue for making the 2017 individual tax cuts permanent, said John Gimigliano, KPMG's head of federal tax legislative and regulatory services.

The Congressional Budget Office estimates this would add $2.8 trillion to its baseline deficit forecast just through 2033 compared with letting them expire under current law.

Democrats will advocate "a return to Build Back Better and see a push on the corporate rate, on the capital gains rate and individual rates and all the things they had hoped to do," Gimigliano said.

Steve Rosenthal, a senior fellow at the left-leaning Urban-Brookings Tax Policy Center in Washington, said it may be difficult for Biden to reprise his "very powerful" 2020 tax agenda.

"Very little of it was accomplished in the Inflation Reduction Act, and nothing was advanced as part of these debt ceiling negotiations," Rosenthal said. "So how credible will Biden be running on a platform of closing loopholes and raising taxes on the rich and corporations?"

https://finance.yahoo.com/news/analysis-us-debt-ceiling-deal-101548585.html

Bayer inks Cedilla cancer deal, betting take on tough target will beat Pfizer

 Bayer is joining Blueprint Medicines, Incyte and Pfizer in the race to develop a selective CDK2 inhibitor, paying Cedilla Therapeutics an undisclosed sum for a preclinical challenger to the more advanced rivals.

Evidence that CDK2 is involved in processes that drive forms of breast, ovarian, uterine, stomach and esophageal cancers has spurred decades of research. Interest in the target intensified as it became clear that the kinase is implicated in changes that create breast cancers that are resistant to CDK4/6 inhibitors such as Pfizer’s Ibrance, Novartis’ Kisqali and Eli Lilly’s Verzenio.

CDK2 is a tough target, though, because researchers need to create molecules with selectivity against its isoforms to avoid an intolerable toxicity profile. Cedilla emerged as a biotech with a plan for how to beat the toxicity problem in 2021, when it disclosed its CDK2 program and raised $82.6 million.

Investors including RA Capital Management and Third Rock Ventures bet on Cedilla in the belief that its conditional inhibitors are a good fit for targets including CDK2. The inhibitors only modulate their targets when they are in a certain condition. 

In the case of CDK2, the condition is binding to Cyclin E. Focusing on the Cyclin E1/CDK2 complex enabled Cedilla to identify a previously unreported binding site. If the biotech is right, targeting the binding site will improve on the selectivity of other CDK2 inhibitors and result in a more favorable risk-benefit profile. 

Bayer has bought into the idea. In return for a financial package featuring upfront, milestone and royalty payments, the size of which remains under wraps, the German drugmaker has secured full rights to work on Cedilla’s Cyclin E1/CDK2 complex inhibitors. The Cedilla pipeline lists the program between preclinical and IND. 

The upshot is Bayer has ceded a head start to its rivals for the CDK2 market. Pfizer is set to present phase 1/2a data on its candidate, PF-07104091, this week. Incyte and Blueprint Medicines joined Pfizer in the clinic last year, kicking off early-phase trials of INCB123667 and BLU-222, respectively. Blueprint was held up by a clinical hold but quickly fixed the problem and began working to resume enrollment in March.

https://www.fiercebiotech.com/biotech/bayer-inks-cedilla-cancer-deal-betting-take-tough-target-will-beat-pfizer-and-chasing-pack